| NCT Number | NCT07715175 |
| Lead Sponsor | InventisBio Co., Ltd |
| Conditions | Renal Impairment |
| Enrollment | 40 participants |
| Start Date | 2026-08-09 |
| Primary Completion | 2026-11-21 (estimated) |
| Study Completion | 2026-11-21 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-23 |